secwatch.observer — SEC 8-K summary
======================================

Issuer:     Valion Bio, Inc. (VBIO)
CIK:        0001787740
Form:       8-K
Filed at:   2024-08-13T23:59:59+00:00
Accession:  0000950170-24-096305
Event type: other_material
Sentiment:  positive
Materiality: 0.75
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Tivic Health stockholders approve 10x increase in equity plan shares to 1M
--------------------------------------------------------------------------

- A&R Plan approved, increasing authorized shares from 92,376 to 1,000,000 (over 10x increase).
- Two Class III directors elected: Jennifer Ernst (654,527 for) and Sheryle Bolton (596,810 for).
- Rosenberg Rich Baker Berman ratified as independent auditor for FY2024 with 2,241,997 votes for.
- Annual meeting quorum of approximately 38.7% (2,395,964 of 6,183,592 shares represented).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1787740/000095017024096305/0000950170-24-096305-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1787740/000095017024096305/tivc-20240809.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-096305

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer